Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
VanEck High Yield Muni ETF
HYD
$4.43B
| $5.05M | ﹤0.01% |
80,844
-2,971
| -4% | -$185K |
|
2352
Camden National
CAC
$978M
| $5.03M | ﹤0.01% |
104,513
+892
| +0.9% | +$42.8K |
|
|
NFBK
2353
DELISTED
Northfield Bancorp
NFBK
| $5.02M | ﹤0.01% |
310,557
-2,647
| -0.8% | -$45.7K |
|
2354
Hyliion Holdings
HYLN
$635M
| $5.01M | ﹤0.01% |
808,383
+17,381
| +2% | +$124K |
|
|
CFB
2355
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $5.01M | ﹤0.01% |
320,859
+3,179
| +1% | +$46.2K |
|
2356
First Mid Bancshares
FMBH
$1.39B
| $5M | ﹤0.01% |
116,810
+2,730
| +2% | +$117K |
|
2357
Clover Health Investments
CLOV
$2.2B
| $4.97M | ﹤0.01% |
1,336,988
+368,986
| +38% | +$2.26M |
|
2358
Zai Lab
ZLAB
$2.06B
| $4.97M | ﹤0.01% |
79,105
+2,565
| +3% | +$217K |
|
|
NGM
2359
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.97M | ﹤0.01% |
280,468
+5,222
| +2% | +$100K |
|
2360
Collegium Pharmaceutical
COLL
$1.15B
| $4.95M | ﹤0.01% |
265,130
-32,096
| -11% | -$626K |
|
|
EGRX
2361
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.95M | ﹤0.01% |
97,142
+15,999
| +20% | +$829K |
|
|
ISEE
2362
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.93M | ﹤0.01% |
294,930
+31,193
| +12% | +$511K |
|
|
DSEY
2363
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $4.93M | ﹤0.01% |
370,169
+26,064
| +8% | +$389K |
|
2364
GrowGeneration
GRWG
$86.5M
| $4.92M | ﹤0.01% |
377,001
+9,476
| +3% | +$182K |
|
2365
Inogen
INGN
$175M
| $4.92M | ﹤0.01% |
144,555
+6,129
| +4% | +$223K |
|
2366
Merchants Bancorp
MBIN
$2.53B
| $4.9M | ﹤0.01% |
155,253
+1,132
| +0.7% | +$34K |
|
2367
Praxis Precision Medicines
PRAX
$8.58B
| $4.88M | ﹤0.01% |
16,517
+656
| +4% | +$192K |
|
|
NWLI
2368
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $4.86M | ﹤0.01% |
22,664
+293
| +1% | +$63.7K |
|
|
BHIL
2369
DELISTED
Benson Hill, Inc.
BHIL
| $4.82M | ﹤0.01% |
+18,904
| New | +$4.57M |
|
2370
Scholar Rock
SRRK
$5.67B
| $4.82M | ﹤0.01% |
194,101
+9,213
| +5% | +$254K |
|
2371
PureCycle Technologies
PCT
$1.28B
| $4.78M | ﹤0.01% |
498,909
+72,540
| +17% | +$875K |
|
2372
Mercantile Bank Corp
MBWM
$1.04B
| $4.77M | ﹤0.01% |
136,072
+1,740
| +1% | +$60.6K |
|
2373
Grupo Cibest SA
CIB
$22B
| $4.76M | ﹤0.01% |
150,684
+4,747
| +3% | +$160K |
|
|
ONT
2374
Onterris Inc
ONT
$759M
| $4.75M | ﹤0.01% |
67,437
+9,058
| +16% | +$628K |
|
2375
AnaptysBio
ANAB
$1.58B
| $4.74M | ﹤0.01% |
136,312
+674
| +0.5% | +$21.4K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.